Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Revolution hits public markets in $238m IPO
The precision cancer therapy developer, which counts Sanofi as a significant shareholder, floated at the top of an upsized range and saw its price continue to rise post-IPO.
Beam Therapeutics brings IPO to $207m close
The genomic drug developer, which counts GV as an investor, has completed its initial public offering, boosting its size from $180m to $207m.
Schrödinger shuts IPO at $232m
Drug and materials development software provider Schrödinger has capped a successful initial public offering at more than $232m.
Schrödinger shakes out $202m from IPO
The GV and Wuxi AppTec-backed drug development software producer floated above its range and saw its shares rise 68% on their first day of trading.
Beam Therapeutics shines in $180m IPO
Alphabet, Editas and Bio Palette-backed genomic medicine developer Beam will raise $180m in an upsized initial public offering three years after being spun out of Harvard University.
Casper catches $100m in initial public offering
The Target-backed mattress and bedding brand is floating at the bottom of its range, at a valuation of less than half that of its last funding round.
VisasQ to visit Tokyo listing
Tokyo’s Mothers Market has approved an IPO for the business knowledge-sharing platform that would allow CyberAgent, DA Consortium and Mizuho Bank to exit.
Revolution sets range for IPO
The Sanofi-backed cancer therapy developer is set to raise between $140m and $160m in its initial public offering following $226m in funding.

Other News

Passage Bio reaches IPO stage
The CNS disorder-focused drug developer has filed to raise up to $125m having raised $226m in funding from backers including Eli Lilly and Access Industries.
iFlix forsakes IPO for more fundraising
The online streaming platform is seeking a reported $50m from existing investors that include JTBC, Yoshimoto Kogyo, MNC, Liberty Global, Sky, PLDT, Zain Group and Hearst.
One Medical wanders onto public markets with $245m
The GV-backed primary care membership service floated at the bottom of its range but garnered a valution of more than $1.7bn.
Schrödinger shoots for $160m in IPO
Wuxi AppTec and Alphabet are in line to exit the molecule-discovery software provider, which has set the range for its initial public offering.
Revolution Medicines to rule with $100m IPO
Sanofi is in line for an exit as Revolution Medicines files for a $100m initial public offering on the Nasdaq Global Market.
UCloud stars in $284m IPO
Bertelsmann achieved an exit as the cloud services provider raised $284m in an initial public offering that reportedly valued it at about $2bn.

Editor's Picks fills up with $216m IPO
Financial automation software producer Bill is floating above its range as Fleetcor, Mastercard, Amex and a host of banks all scored exits.
Peloton pulls itself to billion-dollar IPO
Comcast NBCUniversal and Grace Beauty scored exits as Peloton Interactive floated at the top of its range to raise $1.16bn, getting a further $100m in a private placement.
Cloudflare clocks up $525m in IPO
Alphabet, Baidu, Microsoft and Qualcomm all notched up exits as the cloud services provider floated above a range that had already been increased.
Megvii makes for Hong Kong to IPO
The Alibaba and Foxconn-backed facial-recognition technology developer has filed for an offering that is reportedly set to raise $500m to $1bn.
test reg